Gain Therapeutics (GANX)
(Delayed Data from NSDQ)
$1.12 USD
-0.08 (-6.67%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $1.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Gain Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -22.27 | -17.59 | -13.89 | -3.58 | -2.19 |
Depreciation/Amortization & Depletion | 0.08 | 0.06 | 0.02 | 0.01 | 0.00 |
Net Change from Assets/Liabilities | 0.44 | 1.51 | -0.39 | 0.24 | 0.31 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.88 | 1.32 | 1.89 | 0.09 | 0.01 |
Net Cash From Operating Activities | -18.87 | -14.69 | -12.37 | -3.24 | -1.87 |
Property & Equipment | -0.02 | -0.12 | -0.09 | -0.02 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 10.24 | -14.66 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 10.22 | -14.77 | -0.09 | -0.02 | -0.01 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 12.73 | 0.00 | 42.64 | 10.22 | 1.75 |
Issuance (Repayment) of Debt | -0.09 | -0.08 | -0.02 | 0.74 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -0.85 | -0.47 | 0.00 |
Net Cash from Financing Activities | 12.64 | -0.08 | 41.77 | 10.49 | 1.75 |
Effect of Exchange Rate Changes | 0.49 | -0.02 | 0.10 | -0.04 | 0.03 |
Net Change In Cash & Equivalents | 4.49 | -29.57 | 29.41 | 7.19 | -0.10 |
Cash at Beginning of Period | 7.34 | 36.91 | 7.50 | 0.31 | 0.41 |
Cash at End of Period | 11.83 | 7.34 | 36.91 | 7.50 | 0.31 |
Diluted Net EPS | -1.71 | -1.48 | -1.37 | -1.17 | NA |
Fiscal Year End for Gain Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -4.01 | -22.27 | -17.54 | -12.83 |
Depreciation/Amortization & Depletion | NA | 0.02 | 0.08 | 0.06 | 0.04 |
Net Change from Assets/Liabilities | NA | 0.42 | 0.44 | 1.82 | 1.82 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -0.01 | 2.88 | 2.46 | 1.73 |
Net Cash From Operating Activities | NA | -3.59 | -18.87 | -13.21 | -9.24 |
Property & Equipment | NA | 0.00 | -0.02 | -0.02 | -0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 3.02 | 10.24 | 7.10 | 5.17 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 3.02 | 10.22 | 7.08 | 5.15 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.16 | 12.73 | 3.15 | 2.99 |
Issuance (Repayment) of Debt | NA | -0.02 | -0.09 | -0.07 | -0.04 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.28 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -0.15 | 12.64 | 3.08 | 2.95 |
Effect of Exchange Rate Changes | NA | -0.44 | 0.49 | 0.01 | 0.15 |
Net Change In Cash & Equivalents | NA | -1.16 | 4.49 | -3.04 | -0.99 |
Cash at Beginning of Period | NA | 11.83 | 7.34 | 7.34 | 7.34 |
Cash at End of Period | NA | 10.67 | 11.83 | 4.30 | 6.35 |
Diluted Net EPS | NA | -0.22 | -0.29 | -0.37 | -0.62 |